Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03981861 · ClinicalTrials.gov registry record · Phase 2
Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents
A Phase 2 study of PCOS, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03981861 is a Phase 2 study of PCOS that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 12 participants, below the 82-participant average among 8 other PCOS trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03981861, a Phase 2 study of PCOS, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To exam in the effect of a combination of low dose Metformin and Spironolactone on functional brain MRI, menstrual regulation and metabolism in adolescents with PCOS.
Conditions Studied
Interventions
- DRUG Metformin and Spironolactone
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07-02 |
| Est. Completion | 2019-06-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03981861
The ClinicalTrials.gov registry entry for NCT03981861 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 82-participant average among 8 other PCOS trials with a reported enrollment target (85% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with PCOS appearing as the primary indexed condition, and to 1 intervention - of which Metformin and Spironolactone is the first listed.
NCT03981861 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT03981861 about?
NCT03981861 is a clinical study titled "Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents". To exam in the effect of a combination of low dose Metformin and Spironolactone on functional brain MRI, menstrual regulation and metabolism in adolescents with PCOS.
What is the current status of trial NCT03981861?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2016-07-02. Estimated completion is 2019-06-05.
What conditions does trial NCT03981861 study?
This clinical trial studies the following conditions: PCOS.
What interventions are being tested in trial NCT03981861?
The interventions under investigation include: Metformin and Spironolactone (DRUG).
Who is sponsoring clinical trial NCT03981861?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03981861 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PCOS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
COMPLETED · Phase 2
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
-
Androgens and NAFLD Longitudinal Cohort Study
RECRUITING
-
In Vitro Maturation of Human Eggs
RECRUITING · NA
-
Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
ACTIVE NOT RECRUITING · Phase 4
-
Transcriptional and Epigenetic Program of PCOS Women
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.